Blog · svježe, s datumom, s izvorima
GLP-1, ažurno — što se promijenilo i što pokazuju podaci u 2026.
Objašnjenja koja prvo odgovaraju na pitanja koja ljudi ove godine doista traže, svako utemeljeno na FDA propisnim informacijama i recenziranim ispitivanjima. Za trajne temelje krenite od naših GLP-1 vodiča.
Microdosing GLP-1 in 2026
Microdosing GLP-1 medications is everywhere — but what does the evidence say? An honest look at what it means, why people do it, and what's known about safety.
Missed Your Wegovy Dose? (2026)
Missed a Wegovy shot? The '2-day' and '4-day' rules get confused online. Here's the FDA-label answer for Wegovy: when to take it late, and when to skip.
Oral GLP-1 Tracking in 2026
How the daily oral GLP-1 tablet schedule works, why the empty-stomach rule is non-negotiable, and what's worth tracking when your GLP-1 is a pill, not a shot.
Protein target on GLP-1 (g/kg), 2026 guide
How much protein should you aim for on a GLP-1? A source-backed look at targets in grams per kilogram, and how to hit the number when your appetite is low.
Semaglutide mg to Units (2026)
Converting a semaglutide dose from mg to insulin-syringe units? The answer depends on your vial's concentration — here's the arithmetic, and why charts are risky.
Zepbound Plateau at Week 12? (2026)
Stalled on Zepbound around week 12? Before assuming tirzepatide stopped working, check dose timing, steady state and titration stage — from the FDA label.
Edukativni sadržaj — nije medicinski savjet. Svaki članak sastavljen je iz FDA propisnih informacija i citiranih kliničkih ispitivanja; pogledajte našu uredničku politiku za informacije o tome kako se pišu i ažuriraju.
Čitanje je dobro. Vođenje evidencije je bolje.
Pratite putovanje koje opisuju ovi članci — besplatno.